| Market revenue in 2024 | USD 490.1 million |
| Market revenue in 2030 | USD 648.1 million |
| Growth rate | 4.8% (CAGR from 2025 to 2030) |
| Largest segment | Dietary supplements |
| Fastest growing segment | Hormonal |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Hormonal, Non-Hormonal, Dietary Supplements |
| Key market players worldwide | Bayer AG, AbbVie Inc, Abbott Laboratories, Nestle SA, Dr Reddy's Laboratories Ltd ADR, Theramex, Rainbow Light Nutritional Systems, Padagis |
The NHS has identified the average age of menopause in women as 51 years in the UK, with exceptions that enter menopause before 40 years of age or even in their 30s. It estimated around 13 million women, or around one-third of the female population in the UK, being premenopausal or menopausal. Considering the large target population, researchers are innovating products to ease the transition of women through menopause.
Cambridge Diagnostic Imaging (CaDi), a provider of nutraceutical products for health support, announced the launch of Lycovary Daily in December 2020. The product is a food supplement developed by a biotech company, Lycotec, designed for ovarian health. It provides targeted anti-aging oxygenation, supporting women through the fertile phase and menopause transition.
Publish Date: May 30, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Abbott Laboratories | View profile | 114,000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | www.abbottinvestor.com |
| Dr Reddy's Laboratories Ltd ADR | View profile | 22,822 | 8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, India, 500 034 | www.drreddys.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Nestle SA | View profile | 270,000 | Avenue Nestle 55, Vevey, Switzerland, CH-1800 | www.nestle.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Theramex | View profile | 251-500 | London, England, United Kingdom, Europe | theramex.com/ |
| Rainbow Light Nutritional Systems | View profile | 51-100 | Santa Cruz, California, United States, North America | www.rainbowlight.com/ |
| Padagis | View profile | 251-500 | Allegan, Michigan, United States, North America | www.padagis.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Menopause Market Outlook will help companies and investors design strategic landscapes.
Dietary Supplements was the largest segment with a revenue share of 98.12% in 2024.
Horizon Databook has segmented the U.K. menopause market based on hormonal, non-hormonal, dietary supplements covering the revenue growth of each sub-segment from 2018 to 2030.
The NHS has identified the average age of menopause in women as 51 years in the UK, with exceptions that enter menopause before 40 years of age or even in their 30s. It estimated around 13 million women, or around one-third of the female population in the UK, being premenopausal or menopausal. Considering the large target population, researchers are innovating products to ease the transition of women through menopause.
Cambridge Diagnostic Imaging (CaDi), a provider of nutraceutical products for health support, announced the launch of Lycovary Daily in December 2020. The product is a food supplement developed by a biotech company, Lycotec, designed for ovarian health. It provides targeted anti-aging oxygenation, supporting women through the fertile phase and menopause transition.
Horizon Databook provides a detailed overview of country-level data and insights on the U.K. Menopause Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into U.K. Menopause Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
